ASA Advises Monitoring for Exhaled Carbon Dioxide During Upper GI Procedures

The American Society of Anesthesiologists’ Ambulatory Surgical Care committee issued a statement, advising anesthesiologists to consider monitoring patients for exhaled carbon dioxide in procedures using propofol, especially involving the upper GI tract.

Advertisement

The ASA’s statement reads:

“Monitoring for exhaled carbon dioxide should be considered during endoscopic procedures in which sedation is provided with propofol alone or in combination with opioids and/or benzodiazepines, and especially during these procedures on the upper gastrointestinal tract. Careful attention to airway management must be provided during endoscopic retrograde cholangiopancreaticography (ERCP) procedures performed in the prone position where ventilatory monitoring, airway maintenance, and resuscitation may be especially difficult.”

Learn more about the ASA.

Advertisement

Next Up in Patient Safety & Outcomes

  • Seven nursing specialties reported turnover rates above the national average in 2024,  according to the NSI National Health Care Retention…

  • Respiratory virus season is in full gear, with flu admissions rising quickly in recent weeks, according to the latest national…

Advertisement

Comments are closed.